Evidence map›Paper›PMID 29051379›Full record

ArticleScience (New York, N.Y.)2017

Ectopic colonization of oral bacteria in the intestine drives T

Koji Atarashi, Wataru Suda, Chengwei Luo, Takaaki Kawaguchi, Iori Motoo, Seiko Narushima, Yuya Kiguchi, Keiko Yasuma, Eiichiro Watanabe, Takeshi Tanoue and 16 more

2 registry-linked trialsAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 583 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
583citing papers in PubMed, 7 pooled it
22.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06312683 phase4recruitingnot on this mapstarted 2024, after this paper: background citation

Rifaximin for the Secondary Prevention of Recurrent Pouchitis

TypeinterventionalSponsorUniversity of North Carolina, Chapel HillRan2024 to 2027Enrolled16ConditionsPouchitisArmsRifaximin 550 MG Oral Tablet [XIFAXAN]
NCT06864403 phase4recruitingnot on this mapstarted 2025, after this paper: background citation

Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch

TypeinterventionalSponsorUniversity of North Carolina, Chapel HillRan2025 to 2027Enrolled25ConditionsPouchitis, Pouches, Ileoanal, Pouch, IlealArmsMirikizumab - Intravenous (IV), Mirikizumab - Subcutaneous (SC)
3 · Its place in the literature

Who cites it

583 citing papers in PubMed, 7 syntheses or guidelines pooled it, 907 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

523 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors at 12 institutions in 5 countries.

Koji AtarashiDepartment of Microbiology and Immunology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.ORCID 0000-0001-5422-0736
Wataru SudaDepartment of Microbiology and Immunology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.ORCID 0000-0002-2861-9724
Chengwei LuoBroad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Takaaki KawaguchiDepartment of Microbiology and Immunology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.ORCID 0000-0002-3354-961X
Iori MotooRIKEN Center for Integrative Medical Sciences, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa 230-0045, Japan.
Seiko NarushimaRIKEN Center for Integrative Medical Sciences, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa 230-0045, Japan.ORCID 0000-0002-3001-2446
Yuya KiguchiGraduate School of Frontier Sciences, The University of Tokyo, 5-1-5 Kashiwanoha, Kashiwa, Chiba 277-8561, Japan.ORCID 0000-0003-3334-2018
Keiko YasumaDepartment of Microbiology and Immunology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.ORCID 0000-0001-7102-987X
Eiichiro WatanabeRIKEN Center for Integrative Medical Sciences, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa 230-0045, Japan.ORCID 0000-0003-2050-3740
Takeshi TanoueDepartment of Microbiology and Immunology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
Christoph A ThaissDepartment of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.
Mayuko SatoRIKEN Center for Sustainable Resource Science, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa 230-0045, Japan.ORCID 0000-0002-9876-5612
Kiminori ToyookaRIKEN Center for Sustainable Resource Science, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa 230-0045, Japan.ORCID 0000-0002-6414-5191
Heba S SaidCooperative Major in Advanced Health Science, Graduate School of Advanced Science and Engineering, Waseda University, Tokyo, Japan.
Hirokazu YamagamiDepartment of Gastroenterology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Scott A RiceThe Singapore Centre for Environmental Life Sciences Engineering, The School of Biological Sciences, Nanyang Technological University, Singapore.ORCID 0000-0002-9486-2343
Dirk GeversBroad Institute of MIT and Harvard, Cambridge, MA 02142, USA.ORCID 0000-0003-1998-0363
Ryan C JohnsonMicrobial Genomics Section, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA.ORCID 0000-0002-2114-2951
Julia A SegreMicrobial Genomics Section, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA.ORCID 0000-0001-6860-348X
Kong ChenRichard King Mellon Foundation Institute for Pediatric Research, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15224, USA.ORCID 0000-0001-6980-5454
Jay K KollsRichard King Mellon Foundation Institute for Pediatric Research, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15224, USA.
Eran ElinavDepartment of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.
Hidetoshi MoritaGraduate School of Environmental and Life Science, Okayama University, Okayama, Japan.
Ramnik J XavierBroad Institute of MIT and Harvard, Cambridge, MA 02142, USA.ORCID 0000-0002-5630-5167
Masahira HattoriGraduate School of Frontier Sciences, The University of Tokyo, 5-1-5 Kashiwanoha, Kashiwa, Chiba 277-8561, Japan. m-hattori@aoni.waseda.jp kenya@keio.jp.ORCID 0000-0001-9467-0344
Kenya HondaDepartment of Microbiology and Immunology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. m-hattori@aoni.waseda.jp kenya@keio.jp.ORCID 0000-0001-8937-9835
Keio University · JPBroad Institute · USRIKEN Center for Integrative Medical Sciences · JPWaseda University · JPNational Human Genome Research Institute · USRIKEN Center for Sustainable Resource Science · JPUniversity of Pittsburgh · USWeizmann Institute of Science · ILNanyang Technological University · SGOkayama University · JPOsaka City University · JPThe University of Tokyo · JP

Funding

Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG · 1991 to 2026
$35.3M
Microbial genomics of hospital-associated pathogensZIAHG200382 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI SEGRE, JULIA ANGELA · 2012 to 2025
$9.1M
Th17 Cytokines and Lung ImmunityR37HL079142 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KOLLS, JAY K · 2010 to 2017
$3.6M
Autophagy genes and the microbiome in Crohn's DiseaseR01DK092405 · NIDDK · BROAD INSTITUTE, INC. · PI XAVIER, RAMNIK J · 2012 to 2014
$2.0M
NHLBI NIH HHS R37 HL079142NIDDK NIH HHS P30 DK043351NIDDK NIH HHS R01 DK092405
6 · The paper itself

Abstract

Intestinal colonization by bacteria of oral origin has been correlated with several negative health outcomes, including inflammatory bowel disease. However, a causal role of oral bacteria ectopically colonizing the intestine remains unclear. Using gnotobiotic techniques, we show that strains of

Indexed as

AnimalsAnti-Bacterial AgentsDrug Resistance, BacterialDysbiosisGerm-Free LifeInflammatory Bowel DiseasesIntestinesKlebsiellaMiceMice, Inbred BALB CMice, Inbred C57BLMicrobiotaMouthSalivaTh1 CellsAnti-Bacterial Agents

Identifiers

PMID29051379
PMCPMC5682622
OpenAlexW2767008704

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.